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Abstract
Under the Directive 2011/24/EU, medical tourism and cross-border health are interrelated
terms regarding the freedom to move to get the most accessible medical treatment into EU
Member State within the defined procedures for reimbursement.  Little  known empirically
regarding the efficiency of the cross-border health/medical tourism industry. This study aims
to measure its efficiency in Europe for the years 2010-2014, by using Data Envelopment
Analysis  (DEA).  Data  obtained  from  OECD  and  the  European  Core  Health  Indicators
(ECHI), which is collecting the data through Eurostat. Eurostat collects data on health care
activities and provides data on hospital discharges, including the hospital discharges of non-
residents  and  these  include  hospital  discharges  of in-patients and  day  care  patients.  The
analysis uses “DEA.P, 2.1 for windows” by Coelli (1996). The results show that the Members
States health systems were very efficient in handling non-residents in-patients, however when
managing  day  cases/outpatients  the  efficiency  scores  dropped.  The  findings  would  have
significant associations affecting intentions to revisit clinics and the destination country. In
addition, will be useful to those seeking a better understanding of the cross-border health and
medical  tourism industry efficiency. Extending the  findings  of  the  European Commission
report (2015c) by examining how well medical tourists are informed about the decision they
are making, would be of perceived value. These are important indicators at European level by
helping each Member State to measure its medical tourism services. 
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1. Introduction
In June 2010, the European Commission adopted the Communication, ‘Europe, the
world's No. 1 tourist destination – a new political framework for tourism in Europe’. This
communication set out a new strategy and action plan for EU tourism. Tourism has a wide-
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ranging  impact  on  growth,  employment  and social  development  in  the  EU.  The inbound
tourism is contributing €356 billion in annual revenue to the European Economy (European
Commission 2017b). In EU policy debates, cross-border care also often refers to short and
long term visitors to another EU country who find that they have to seek health care when
they are abroad. These two categories include those who fall ill when abroad and those who
go abroad for planned treatment (WHO 2014). Temporary visitors abroad include individuals
travelling  for  work  and  for  leisure  (WHO  2014).  According  to  WHO  (2014)  temporary
visitors are those who have travelled abroad for work and for leisure, and cross border health
can  be  for  them the  most  accessible  or  appropriate  care. There  has  been  a  considerable
increase in the volume of tourism in Europe, with especially large numbers travelling from
northern to southern Europe in summer (Patterson 2006).  Medical tourism refers to people
traveling to a country other than their own to obtain medical treatment (Horowitz et al. 2007,
Horowitz et al. 2007). Medical tourism will play a significant role in shaping the future of
medical care globally, as it sits at the growing intersections of technology, economy, cultural
and other global relations (Jenner 2008). 
Health has always been on the European agenda. Several factors make health policies
and the health systems across the European Union increasingly interconnected: i)  patients
receive healthcare across the EU, ii) health professionals work in different EU countries, iii)
higher expectations for healthcare, iv) new developments in health technologies (European
Commission 2017). 
The number of individuals choosing to travel across national borders or overseas to
receive medical treatments has been on the rise (European Commission 2014). Making cross-
border  health  care  for  European Union  (EU)  citizens  possible,  the  Directive  2011/24/EU
makes it easier for EU citizens to get medical treatment in another EU Member State and
ensure that  at  least  some of the costs  are reimbursed in their  own country. However, the
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Directive emphasises that Member States retain responsibility for providing safe, high-quality
care on their territory, and that care should be provided according to their own standards of
quality and safety. Health system performance is key to achieving the maximum that could be
expected given the level of resources. Countries need to measure how well the health systems
achieve to manage the arrival of the non-resident patients seeking treatment. Measurement of
performance requires an explicit  framework defining the goals of a  health  system against
which outcomes can be judged and performance quantified. Performance comparison efforts
are  still  in  their  early  stages  and  there  are  many challenges  involved  in  the  design  and
implementation of comparison schemes. 
Cross-border  health  including  medical  tourism has  become  a  simpler  way to  get
treatment  abroad;  and  for  temporary  visitors  such  as  medical  tourists,  can  be  the  most
accessible  or appropriate  care. Little  is  known empirically regarding the efficiency of the
cross-border health/medical tourism industry. This study aims to measure the efficiency of the
cross-border health/medical tourism industry for the years 2010-2014. 
2. Cross border health  
The EU has a compendium of Directives dealing with health issues; with laws and
Directives applying to the most crucial areas such as cross-border health including medical
tourism. European Union’s Treaty and its Charter of Fundamental Rights (C364/1 2000) and
the EU institutions are bound to principles that ensure a high level of health protection. These
are the right to benefit from medical treatment; access to healthcare - preventive, diagnostic
and  curative  treatment  regardless  of  financial  means,  gender  or  nationality  (European
Commission 2015a). The Directive 2011/24/EU on the application of patients’ rights in cross-
border healthcare came into force on 24 April 2011 and aims to provide all EU citizens with
equal access to quality healthcare, responding to their specific needs (European Commission
2015b). In 2014 the Communication on health systems shows that the Commission promotes
3
cooperation at EU level with a view to strengthen effectiveness, increase accessibility and
improve resilience of the national health systems in the EU (European Commission 2014). In
2015 the European Commission released a report on the “Operation of Directive 2011/24/EU
on  the  application  of  patients’  rights  in  cross-border  healthcare”  (European  Commission
2015c). 
Moreover, it has released two Eurobarometers; one on patients’ rights in cross-border
healthcare in the European Union (Eurobarometer 2015/425) and one on the preferences of
Europeans towards tourism (Eurobarometer 2015/414). 
The first Eurobarometer (2015/425) describes that as for the proportion of Europeans
who reported that they actually received medical treatment in another Member State, there
was a relatively small difference from one EU country to another. The findings show that in
eight Member States, the percentage of people who used cross-border healthcare in another
EU Member State at greater than 5% were Luxembourg (LU) 16%, 12% Italy (IT) and 10% in
Hungary (HU). Other countries which ranked above the average were Romania (RO) (8%),
Portugal (PT) (7%), Czech Republic (CZ) (7%), Poland (PO) (7%) and Ireland (IE) (6%). The
high rates observed in LU compared to other EU countries may be because its population is
made up of many citizens from other Member States who are therefore more likely to seek
healthcare abroad. For 27% of the respondents, language was a major obstacle to receiving
healthcare abroad, which could actually make them feel more vulnerable. 23% of respondents
would want to know the waiting times for the treatment they are looking for and the same
proportion would want information on healthcare providers (Eurobarometer 2015/425).
The second Eurobarometer (2015/414) under study, showed that spending time in the
sun or at the beach continues to be the main reason for going on holiday, and the second
reason for going on holidays was health treatment with a respondence of one person in eight
(13%). Very high scores were observed in PT, Latvia (LV), Sweden (SE), MT, Hungary (HU),
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and Slovakia  (SK).  It  is  worth  mentioning that  holidaymakers  reported  factors  related  to
sports  or  health  not  as  the  main  motive  for  their  main  vacation  in  2010 (3%) but  as  an
important factor boosting their holidays’ choice. 
These two Eurobarometers showed that health problems within the medical tourism
spectrum can be an opportunity for travelling and accessing quality health care treatments in
another country. 
In 2016, the European Commission released a study aiming to contribute to effective
cross-border cooperation between EU-Member States by means of pooling resources for high-
cost medical equipment investments (European Commission 2016). 
The  aforementioned  reports  and  Eurobarometers  showed  that  the  European
Commission is putting a considerable effort into simplifying the process of travelling abroad
and getting treatment. 
3. Medical tourism
Health tourism is defined as "the organized travel outside one's local environment for
the maintenance, enhancement or restoration of an individual's wellbeing in mind and body".
A subset  of  this  is  medical  tourism,  which  is  "the  organized  travel  outside  one's  natural
healthcare jurisdiction for the enhancement or restoration of the individual's health through
medical intervention" (Carrera and Bridges 2006).  In the past, this usually referred to those
who travelled from less-developed countries to major medical centers in highly developed
countries for treatment unavailable at homes (Horowitz et al. 2007, Horowitz et al. 2007).
Medical tourism is becoming increasingly popular, is driven by marketplace forces and occurs
outside of the view and control of the organised healthcare system (Horowitz et al. 2007).
Medical tourism is one growing dimension of health care globalisation, whereby consumers
elect to travel across borders or to overseas destinations to receive their treatment (Lunt and
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Carrera 2010). There are some of the interrelationships between different areas of health and
medical tourism, including wellness and wellbeing tourism, dental tourism, stem cell tourism,‐
transplant tourism, abortion tourism, and xeno tourism. Key to defining these areas are the‐
relationships to concepts of wellness and illness and the extent to which regulation encourages
individuals to engage in cross border purchase of health services and products (Hall 2011). ‐
At  the  international  level,  health  tourism is  an  industry  sustained  by 617  million
individuals with an annual growth of 3.9% annually and worth US$513 billion (Carrera and
Bridges  2006).  The  medical  tourism industry  is  a  fast-growing  global  niche  market  that
generated $20 billion in income for destinations around the world (Woo and Schwartz 2014).
Some  estimates  on  medical  tourism between  countries  are  made  by consultancies  in  the
process of assessing the potential of the medical tourism business. They range from estimates
based  on  Deloitte’s  2008  report  on  medical  tourism,  quantifying  the  number  of  people
travelling abroad for healthcare at  30 and 50 million each year (Keckley and Underwood
2008). Also, according to the Global Wellness Tourism Economy (2013), medical tourism
market is worth US$50-60 billion. The latest projection on medical tourism is estimated to be
$100  billion  dollar  industry  (Fetscherina and  Stephano 2016). There  are  several  studies
providing estimate on medical tourism growth, but they are based on US figures (Keckley and
Underwood 2008, Gan et al. 2011, Gan et al. 2012, Jacobs et al. 2013). To provide reliable
and accurate data on the flow of medical tourists is very hard as agreed by other authors,
because most of the records are held by private entities (Johnson and Garman 2010, Turner
2012, Lunt et al. 2012). Data collection, measures, and studies of medical tourism all need to
be greatly improved if countries are to assess better both the magnitude and potential health
implications  of this  trade (Hopkinset  al.  2010).  Despite  the increasing number of  people,
companies  and countries  involved in  medical  tourism,  very little  is  known about  the key
drivers and how countries are perceived as medical tourism destinations. Studies have tried to
6
estimate the costs and the benefits of medical tourism (Hanefeld et al. 2013; Beladi et al.
2015); to investigate the understanding of the factors that influence the travel intentions of
medical  tourists  through  its  empirical  investigation,  and  especially  in  its  targeting  of
customers' value perception (Wang 2012); to investigate the decision to engage in medical
tourism (Runnels and Carrera 2012); or to investigate tourist executives’ opinions, aspects and
beliefs  in  medical  tourism  and  examine  factors  affecting  their  potential  investments
(Sarantopoulos  et  al.  2014);  and  to  explain  the  development,  functioning,  purposes  and
possible implications of cross-border contracting (Glinos et al. 2010). Other studies suggest
and test a mechanism to assess the medical tourism providers, perceptions about the tourists,
perceived important product attributes when selecting a medical tourism destination (Woo and
Schwartz  2014).  In addition,  research has  been conducted to  develop a  model  explaining
international  medical  travellers’ intention  formation  by considering  the  impact  of  quality,
satisfaction, trust, and price reasonableness (Han and Hyun 2015) or to develop a model by
introducing  and  explaining  main  elements  of  medical  tourism  such  as  types  of  medical
tourists (Ko 2011). 
Measuring the medical tourism industry efficiency through frontier methods such as
Data Envelopment Analysis (DEA) method has not been performed. To our knowledge, this is
the first  study trying to use available data that would provide evidence on measuring the
efficiency of the cross-border health/medical tourism industry in the EU, by using DEA. DEA
analysis  has been widely used in other  economic sectors since 1957 by (Farrell  1957) as
organisations have struggled to improve productivity and efficiency. DEA has a long history
with lots of important publications in measuring efficiency of hospitals and clinics (Caves et
al. 1982, Lovell 1996, Cook and Seiford 2009, Charnes et al. 1978, Färe et al. 1994, Coelli et
al. 2005, Coelli and Perelman 1996, Hollingsworth et al. 1999, Färe et al. 1989, Halkos and
Tzeremes 2010, Ancarani et al. 2009, Maniadakis et al. 2007, Androutsou et al. 2011, Staat
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2006, Geitona et al. 2013, Pulina et al. 2010, Khushalani and Ozcan 2017, Steinmann and
Zweifel, 2003; Leleu et al., 2014; Samut and Cafrı, 2016; Moran and Jacobs, 2013, Linna et
al. 2006, Varabyova and Schreyögg 2013, Medina et al. 2013).  
DEA method has been also used in tourism industry by measuring the performance of
the hotels  (Assaf  and Agbola 2011,  Barros 2006, Tingting and Liang 2015, Wöber 2008,
Meng-Chun et al. 2011, Halenur 2017, Jin-Li Hu 2014, Debata et al. 2013). Therefore, this
method has been selected as it has been used in both industries to measure efficiency and
provide reliable results. 
4. Material and Method
Data was obtained from the Organisation of Economic Co-operation and Development
(OECD)  and  the  European  Core  Health  Indicators  (ECHI),  which  is  collecting  the  data
through Eurostat. Eurostat collects data on health care activities and provides data on hospital
discharges,  including  the  hospital  discharges  of  non-residents  and  these  include  hospital
discharges of in-patients and day care patients. The results were obtained by using “DEA.P
Version 2.1 for windows” by Coelli (1996).
The computation of cross-border health/medical tourism industry efficiency of the EU
Member States has been explored by using the non-parametric mathematical programming
approach – DEA. Efficiency measurement refers to technical efficiency (TE), which aims at
the maximisation of outputs for a given level of inputs, or conversely the minimisation of
input use for a given output level. In this study, an input-oriented measure has been performed
in order to evaluate by how much quantities can be proportionally increased without changing
the output quantities used (Banker et al. 1984, Charnes et al. 1978, Hollingsworth et al. 1999).
The formulation used to define efficiency in this study is described as follows. In order
to characterise production technology related to the efficiency measurement, each clinic uses
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variable inputs  χ = (χ1,…,χN)   RN+  to produce variable outputs y = (y1,…,yM)   RM+ .  The
clinic inputs can be transformed into outputs using technology that can be described by GR =
{(x,y):x can produce y}. Corresponding to the GR, there is a family of input sets L(y) = {x( x,
y)   GR}, y   RM+.  Input sets are assumed to be closed and bounded above, and to satisfy
strong disposability of inputs. The input sets contain isoquants Isoq L(y) = {x : x  L(y), θx 
L( y ),θ  (0,1)}, y   RM+. Also corresponding to the GR of the technology is a family of
output sets P (x) = {y :( y,x)   GR}, x   RN+.  Output sets are assumed to be closed and
bounded above, and to satisfy the properties of convexity and strong disposability of outputs.
A Farrell radial measure of the technical efficiency of input vector x in the production of
output  vector  y is  given by:  TE(x,y)  = min {θ:θx   L(y)},  where  θ = 1 indicates radial
technical efficiency and θ < 1 shows the degree of radial technical inefficiency. 
DEA efficiency scores at EU Member States, are related to the relative efficiency of
the services provided by each Member State or to inefficiencies related to the excessive and
incorrect input utilisation. Fully efficient EU Member States per year are those which score
1.00 and achieve the highest performance, 100% efficiency scores. Inefficiency or minimum levels
of performance refer to any regressed scores below 1.00 or below 100% efficiency scores. 
This study runs two (2) models in order to analyse the efficiency of the Member States
health systems when treating non-resident patients. The reason of creating these 2 models is
due  to  data  availability. The study used all  the data  available  per  year  and per  reference
country. The study used as output the indicator hospital discharges of non-residents, which
includes  hospital  discharges  of in-patients and  day care  patients.  Medical  tourists  can  be
classified as a non-resident category of patients that have been discharged by the hospital after
an episode of care. 
The study considers hospitals as a multi-product organisation with the annual number
of practising physicians and practising qualified nurses and midwives per 100,000 inhabitants
9
per EU Member State used as labour inputs and the number of beds as an aggregate proxy of
capital inputs. Table 1 shows the inputs and outputs used in the two models along with a
description of the data used and the sources of the data. In both models, it used three (3)
inputs  (hospital  beds,  total  number  of  practising  physicians,  per  100,000  inhabitants  and
practising qualified nurses and midwives, per 100,000 inhabitants). 
……………………………(Table 1 about here)…………………………………..
The  difference  in  the  two  models  is  that  model  no1  used  two  outputs  (hospital
discharges  in-patients  per  100,000  inhabitants,  number  of  non-resident  people  among  all
people discharged from hospital per 100,000 inhabitants) while model no. 2 used two outputs
by  keeping  the  same  indicator  “the  number  of  non-resident  people  among  all  people
discharged from hospital per 100,000 inhabitants”, but as a second output indicator it used the
day cases/number of outpatients. The indicator on patient  mobility meets the increasingly
important  EU-health policy issue of cross-border  care.  Increased patient  mobility raises  a
number  of  issues  and  concerns  in  Member  States  such  as  health  care  availability  and
utilisation, health infrastructure development, cost sharing and patient safety. Therefore, the
main  indicator  taken  into  consideration  in  measuring  the  efficiency  of  the  cross-
border/medical  tourism industry  is the number  of  non-resident  people  among  all  people
discharged from hospital per 100,000 inhabitants. A non-resident patient is a patient living in
another country/region but coming in the country/region of reference for treatment and/or
care. Each EU Member State is considered as a single Decision Making Unit (DMU) in terms
of provision of in-patient care and day cases/outpatients. The available data provided by more
than one EU Member State per year was for the period 2010 – 2014, therefore the DEA
models were evaluated in  terms of  their  cross-country performance over that  period.  The
study used 49 DMUs for the aforementioned years. 
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The input-oriented method has been chosen due to the fact that the output used in this
study -the non-resident people among all people being discharged– is a source which presents
the arrival of medical visitors to the host Member State hospitals, which regarding to the usual
health  systems procedure is  an indicator  that  in  terms of  budget  and resources  allocation
cannot  be  predicted,  but  is  aggregated  to  the  number  of  “health  care  users”.  A hospital
discharge is the formal release of a patient from a hospital after a procedure or course of
treatment  (episode  of  care)  (ECHI 2017). The inputs  used;  hospital  beds,  and the  human
resources are indicators forming a health care system and can be crucial when planning a
reform to achieve efficiency. 
5. Results
In this paper, EU Member States performance has been assessed by measuring cross-
border/medical tourism industry efficiency through a set of similar DMUs. The results at a
European level by running model no.1, showed that in 2010 all the countries with available
data (HU, IE, LU)] were fully efficient when providing medical treatment to those that are
non-residents.  In  2011  six  [HU,  IE,  LU,  IT),  Slovenia  (SI),  Lithuania  (LT)]  out  of  ten
countries were fully efficient, while CZ and Croatia (HR)] had the lowest efficiency scores. In
2012 six [IE, LU, SI, Malta (MT), RO and Slovakia (SK)] out of fourteen countries were fully
efficient,  while  HR,  CZ and  Spain  (ES)  showed  the  lowest  efficiency scores  among  the
countries studied.  In 2013 five (IE, LU, MT, RO, SI) out of thirteen countries were fully
efficient, while HR and Italy (IT) where those with the least efficient scores. In 2014 four
(LU, SI, MT, RO) out of ten countries were fully efficient, while Germany (DE) showed the
lowest efficiency score. Overall, the countries under study were very efficient, as the ranking
between the scores throughout the years was from the lowest 0.71 (HR) to the highest 1 (LU,
IE, SI, RO and SK). 
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The results by running model no. 2 showed that in 2010, 2011 and 2012 two countries
(IE, LU) out of three, ten and fourteen accordingly, were fully efficient. In 2013 three (IE,
LU, MT) out  of eleven countries scored 1.  In 2014, four out of ten countries were fully
efficient. Throughout the years, IE and LU were fully efficient while HU, CZ, DE and LT
were the least efficient.
By comparing the 2 models the results show that IE and LU were fully efficient run by
both models throughout the years. The rest of the Member States run by Model 1 achieved
better scores than run by Model 2, meaning that they could manage better in-patients than day
cases/outpatients. The Member States with the broader differences in scores between the 2
models are HU, CZ, DE and LT. Figure 1 shows the results of the two models for the time
horizon of the analysis. 
…………………………….(Figure 1 about here)………………………………..
6. Discussion
By considering  the  importance  of  the  cross-border  Directive  2011/24/EU that  was
engaged by the Member States in 2013, this study’s observations were that the efficiency
scores achieved per country were similar through the years before and after this milestone.
The reason that there is no considerable efficiency improvement after 2013 can be due to the
issue that the Directive was not properly disseminated to the citizens, as it was also concluded
by the report regarding the operation of European Commission (2015c) Directive. However, it
is worth mentioning that after 2011 (the year that the Directive was published) more Member
States were collecting data on non-residents patients. The Member States can link this to an
observation that cross border health/medical tourism is gaining a great interest and an early
stage collection of reliable data has been performed. The results also showed that LU and IE
were fully efficient throughout the years of consideration. These results can be linked to the
findings of the Eurobarometer 2015/425, which reported that the percentage of people who
used cross-border healthcare in another EU Member State and was greater than 5% was LU
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and  IE.  LU  high  performance  can  also  be  due  to  the  facts  highlighted  at  the  same
Eurobarometer, that was among the countries that were more open to cross-border healthcare
and  as  an  international  country –  with  population  made up of  many citizens  from other
Member States and many people working in LU but living in neighbouring countries – may
support a health system that needs to respond to non-residents provision of health care on a
daily basis,  meaning that  LU health  system is  more familiar  with the cross-border health
policy. Another factor which was a major obstacle for respondents to travel, was the language.
LU  and  IE  may  be  fully  efficient  also  due  to  the  fact  that  health  professionals  in  both
countries speak fluent English. This encourages patients to use the health care facilities, but
also creates a level of understanding of the health care needs by the health professionals;
which  may lead  to  a  more  efficient  health  system.  Addressing  language barriers  through
interpreters and language training professionals is  also important  for the safety of mobile
patients, but again, these measures have come to be seen as vital for all high-quality care due
to the increasing ethnic heterogeneity of Europe (Legido-Quigley et al. 2007). By comparing
this study’s observations to the Eurobarometer 2015/414 results, the countries with the highest
scores of the population that travelled due to health reason were PT, LV, Malta (MT), Hungary
(HU), Slovakia (SK); these countries were also very efficient in treating non-residents patients
according to the findings of this study. However, the determining factor is whether the cost to
the patient is seen as a barrier to free movement (Legido-Quigley et al. 2007). 
There are some methodological limitations that should be mentioned as the fact that
the data available per year did not include the same countries.  It is worth pointing out that the
efficiency scores could vary if different models were to be run. Data availability in the EU on
provision and utilisation rates of medical tourism is only limited. Institutional barriers such as
European comparison of waiting times to enable patients to make informed choices when
seeking medical care in another Member State, is very limited. The use of the output data
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provides  information  about  the  patients  that  are  non-residence  to  the  host  country  they
received treatment and this data includes those that are medical tourists. However, the data
available does not distinguish groups. Therefore, for the purposes of this study it is assumed
that medical tourists are included in the data of those received cross-border health, as they can
lay in the category of temporary visitors that have travelled abroad for work and/or for leisure
and cross-border care was for them the most accessible or appropriate care. 
In order to create comparable units and avoid heterogeneity of the sample the data
used was from the EU Member States that have provided figures on the number of non-
resident people among all people discharged from hospital per 100,000 inhabitants. Another
important  limitation  refers  to  the  fact  that  outputs  adjusted  for  case-mix  and in-patients’
severity have not been taken into consideration due to the lack of relevant data. Consequently,
the data set used does not reflect output qualitative dimensions, which should constitute a
primary criterion in the evaluation of hospital care. Moreover, TE has been used as an input-
oriented  measure  but  an  output-oriented  measure  including  patients’  satisfaction  of  the
services  may  be  useful  for  long-term  growth  of  the  industry,  as  it  is  an  important  and
commonly used indicator for measuring the quality in health care. It could also be useful to
compare the findings of this study with other studies that have measured the efficiency of
health systems in the sample countries, but this study has put emphasis on the non-resident
patient  discharges  which  is  a  relatively new issue  and  most  of  the  available  comparable
studies have not used such a DEA output.
7. Conclusions
Seeing the necessity for comparative assessment in the hospitals across the EU, this
study comes at the right moment to carry out this research at an EU Member State level, as
efficiency is particularly crucial in the context of defining new areas of potential national
actions such as cross-border health/medical tourism. This study highlighted the fact that cross-
14
border health and medical tourism can be interrelated concepts regarding the freedom to move
to get the most accessible or appropriate medical treatment to any EU Member State within
the defined procedures for reimbursement. The introduction of DEA as a practical research
tool for examining efficiency across EU-Member States hospitals seems to open a path to
evaluate  and  compare  health  system  performance  from  a  cross-border/medical  tourism
perspective. The study presented that the efficiency of this market industry differs between
EU Member States and the reasons are diverse and can be ascribed to lacking information,
differences of national health systems, organisational and administrative hurdles and lacking
political support.
Member States need to put more effort into improving and broadening data collection.
This study proposes further analysis through field surveys at medical clinics, that will enable
measurements  regarding  perceived  quality,  satisfaction,  and  trust  in  the  staff  and  clinic.
Waiting times measurements aiming at EU and international comparisons would also benefit
patients who seek cross-border alternatives for their care.
The outcomes of such study would have significant associations affecting intentions to
revisit  clinics  and  the  destination  country.  Extending  the  findings  of  the  European
Commission report (2015c) by examining how well medical tourists are informed about the
decision they are making, would be of perceived value. These are important indicators to be
considered at the European level and would help each Member State to measure its medical
tourism services. 
Health system performance comparisons have the potential to provide a “rich” source
of evidence as well as to influence policy. Measuring its efficiencies at the regional, local or
even clinical level aiming at offering high quality health care services that would encourage
medical  tourists  to  visit  and/or  revisit  the  countries,  could  potentially  bring  economic
advantages for many EU-Member States. Studies like this can offer a unique tool for policy-
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makers interested in understanding whether their health system is performing as well as it
could while treating patients from abroad -including medical tourists. Growth is a priority in
Europe and the health systems should also aim for it by considering medical tourism as an
incentive.  The  successful  integration  of  European  policies  into  a  local  system,  and  the
endorsement of other Member States best practices, often involves a degree of adaptation to
ensure compatibility with existing structures, that may take time. Therefore, as the degree of
adaption of the EU Directive 2011/24/EU is quite recent and aims to have a beneficial effect
on health care systems, according to the results of this study it is worth to compliment the
Member States for their performance so far. 
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TABLE 1: DEA models’ design
Mode
l 1
Mode
l 2
Source of
data
Inputs Hospital beds x x ECHI/OEC
D
Total  number  of  practising
physicians, per 100,000 inhabitants
x x ECHI/OEC
D
Total  number  of  practising
qualified nurses and midwives, per
100,000 inhabitants
x x ECHI/OEC
D
Output
s
hospital  discharges  in-patients  per
100,000 inhabitants
x ECHI/OEC
D
number  of  non-resident  people
among all people discharged from
hospital per 100,000 inhabitants
x x ECHI/OEC
D
Day cases / number of outpatients x ECHI/OEC
D
FIGURE 1: Comparison of model 1 and model 2 DEA efficiency scores 
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